NARULA, N.; HAMAM, H. Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases: The Powerful Pill. Canadian IBD Today, Toronto, Canada, v. 1, n. S11, p. 2–11, 2023. DOI: 10.58931/cibdt.2023.1S1121. Disponível em: https://canadianibdtoday.com/article/view/1-s11-narula_hamam. Acesso em: 10 may. 2024.